Blue Horseshoe Stocks: DAL Options & More

Delta Airlines Inc. DAL

Despite a tumultuous day for the markets yesterday, and mostly everything taking on a bearish characteristic, we’re still going to go bullish on DAL in the wake of the company’s quarterly earnings report released this morning.

Despite rising fuel costs, the company revealed that profits soared well past expectations as a result of increased demand leading to higher ticket prices.

As we always try to do when a company posts a solid beat, we’ll designate a range of options to place on watch, in this case the DAL Weekly $49.50-52 Calls. We’ll go ahead and track these into the end of the week. DAL stock was already oversold, getting hammered for weeks, so this report may be just the catalyst needed to effect an impressive reversal.



SPDR S&P 500 ETF (SPY)

We had great success with the SPY earlier this week, and we want to come back to it this morning in the wake of the markets getting crushed yesterday. With the amount of uncertainty and potential volatility out there, we want to set ourselves up to have an active idea no matter which way the winds blow.

Should the SPY fall below $276, we will target the SPY Weekly $277 & $276 Puts. If it pulls above $276 we will focus on the $276 and $277 Calls, so either way, we should be able to quickly identify the proper course once trading commences. .


Extended Watchlist: 
SBGL, PRPO, RH, HEAR, CEI, HMY, ACST, HSGX

Blue Horseshoe Stocks: NEPT Review & More

Neptune Technology & Bioresources, Inc. NEPT

To start off the new calendar year on a high note, we’d like to track back to a stock we placed on our radars on the morning of November 28th, and recap the solid bullish performance that followed.

NEPT has been in a general uptrend ever since our alert, and is showing a strong sign that it may continue. Subsequent to our initial report, we observed a low of 1.30 in the stock, and as of the new high achieved to close out last week at 2.44. it marked an increase of 88%

We’ll continue to observe this stock, and will want to see it maintain support at or above the 2.20-area on any pullbacks.


INSYS Therapeutics, Inc. INSY

We formulated an options trading idea for the INSY 01/19 $8 and $9 Calls on Wednesday morning, and on Friday. mentioned that despite only moderate gains in the previous session, that we’d still be looking for our opportunity to come along.

Friday’s session facilitated some solid moves in our highlighted contracts, and current conditions suggest we could see an extension to the already significant gains that were there for the taking to close out the 2017 trading year.

The $8 Calls ran from .90-2.27, for a gain of 152%, while the $9′s traded up from .60 to 1.51, which works out to a 151% move.

INSY has traded as high as 10.25 in premarket trading today, and we will look to roll up our strike price to the $10-level if the stock holds above this morning’s premarket low of  9.75 once the session gets rolling.


Extended Watchlist:
TEUM, WATT, SBGL, SSC, MCIG, AGTK, GLDFF, VPER

Incoming search terms:

  • 244L
  • RAH4
  • schooltu2
  • shallsck
  • soundrqn
  • ZEJ3

Blue Horseshoe Stocks: APC Review & More

Versartis, Inc. VSAR

It isn’t just bullish activity that draws us to a stock. Any type of increase in volatility generally causes us to take note, and the rapid fashion in which VSAR is crashing this morning is about as volatile as it gets. The company failed to meet primary endpoints on its HGH study, and the stock fell through the floor, losing over 80% of its value thus far.

Regardless of the catalyst, whenever such a huge selloff occurs in such a hurried way, we go into bottom-watch mode, and wait for the eventual bounce. So we’ll have VSAR on our radars moving forward, watching for signs of solid support and subsequent rebound.


Anadarko Petroleum Corp. APC

The announcement of an enormous 10% share reduction via buyback program had exactly the effect we suspected it would yesterday, after we signaled a range of calls to observe in our premarket report.

Those targets were the APC 09/29 $47-48.50 Calls and each of them made a move to the upside. We also mentioned we’d be watching them beyond yesterday’s session, and sure enough the stock appears to want to gap up this morning and add to the gains we’ve already witnessed, which were as follows:

$47 Calls – Range: 1-1.60 – Max Gain: 60%
$47.50 Calls - Range: 1.29-1.40 – Max Gain: 9%
$48 Calls – Range:.62-.95 – Max Gain: 53%
$48.50 Calls – Range: .50-.83 – Max Gain: 66%
_____

Fresh Post-Earnings Options Idea:
CarMax, Inc. KMX $69.50-71.50 Calls*

*We never discuss weekly options on a Friday without going out of our way to warn our readers that trading contracts with a weekly expiration on a Friday is exceedingly risky and should only ever be attempted by expert traders!!!


Extended Watchlist:
ETRM, EBIO, S, AKTX, SBGL, CAPR, MNKD

Blue Horseshoe Stocks: ALQA Recap & More

Alliqua, Inc. ALQA

The big winner off our premarket watchlist in yesterday’s report turned out to be ALQA, which had a hard spike early in the session and continued to push more steadily upward over the course of the day leading to a strong close. The activity was fueled by the news that the FDA granted 510(k) clearance for ALQA’a SilverSeal Hydrogel wound dressing.

From its early low of .258 the stock traversed its way up to .45, which goes down as a 74% intraday gain. The move came on nearly forty times the monthly average volume on the stock, and as we just mentioned, it also closed with strength, just a penny below the high of day.

After hours trading also saw the stock achieve a high of .51, and it appears as if it could gap up slightly to start the day. We’ll be on the lookout for signs of a continued uptrend here as we head into this midweek.


Uni-Pixel, Inc. UNXL

Despite looming bankruptcy proceedings for UNXL, our bottom-feeder instincts have kicked in as the stock was punished down to a new all-time lows yesterday and is showing signs of a possible rebound this morning.

This NASDAQ could certainly be on its way to an OTC Markets listing in the future, being nowhere near the minimum bid requirements for the higher exchange. But for the time being, we’re only interested in its immediate situation. Over-abused stocks have had a historical tendency to produce some very nice moves for us as they correct course, so we’re going to place UNXL on watch in coming days.


Rimrock Gold Corp. RMRK

We also wanted to swing back around for a quick update on RMRK this morning. We placed this one on watch last Wednesday morning, catching it before it ran over 300% from .0006-.0025 that afternoon.

After a sharp pullback to .0008 over the ensuing few sessions, the stock  rebounded yesterday, returning to a high of .0019 which marks a 138% swing.

We’ll be watching for it to continue to register higher lows on any further pullbacks. Any stock with this kind of price action and volatility is one that we definitely want to keep a close eye on for more quick strike trade opportunities.


Extended Watchlist:
ABCO, IMGN, IMMU, SBGL, RTNB, ETRM, MBRX

Blue Horseshoe Stocks: LODE, Options & More

Potential Bottom-Plays

Comstock Mining, Inc. LODE - We’re coming across a serious bottom-bounce candidate in LODE this morning. The stock has been in a general downtrend all year long, and was recently beaten back so severely that a rebound was inevitable. That began yesterday, and now we’re very interested to track the activity and see if we can confirm a sustained reversal on this one.

Taking a look at the included snapshot of the LODE chart, it would quite frankly be a little surprising if this play didn’t see a continued rebound, and it’s currently trading up in the premarket, so we’ll surely want to keep an eye peeled as the session kicks off.

Another notable aspect of this play is that the company must find a way to re-attain a share price of at least a dollar by November, or face delisting from the AMEX.

______

MabVax Therapeutics Holdings, Inc. MBVX -  Another similar looking chart striking us as a potential bottom-bounce play. MBVX has been trending down since last fall, and it appears as if it’s ready to make a move off of its recently established annual lows, helped along by a key PR.

The company reported positive phase I results for its MVT-2163 ImmunoPET Imaging Agent, an antibody discovery platform focused on the treatment of cancer. (>>View PR) It’s causing a considerable gap-up here in the premarket, and we’ll be quite interested to follow along with the activity.


The Kroger Co. KR  – Options Idea

KR set its own 52-week lows this spring, and has recently been making a comeback on the chart. They’ve also got earnings coming tomorrow, so we thought we’d formulate an options idea running into that release.

We’ll be looking at the KR Weekly $29 and $30 Calls, which could see some nice action, especially if the company’s earnings beat expectations tomorrow.


Extended Watchlist:
ABIL, MTBC, MBOT, SBGL, LINU, EKSO